{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T02:25:52Z","timestamp":1779416752134,"version":"3.53.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-020"],"award-info":[{"award-number":["2021-I2M-1-020"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32293213"],"award-info":[{"award-number":["32293213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171447"],"award-info":[{"award-number":["82171447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571662"],"award-info":[{"award-number":["82571662"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.apsb.2026.02.017","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:00:36Z","timestamp":1772096436000},"page":"2964-2981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reblastatin as a neuroprotective agent in temporal lobe epilepsy and excitotoxic conditions of Alzheimer's disease and Parkinson's disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Xiuneng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longze","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4018-1190","authenticated-orcid":false,"given":"Qi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.02.017_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.apsb.2026.02.017_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.02.017_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.674483","article-title":"The pharmacoresistant epilepsy: an overview on existent and new emerging therapies","volume":"12","author":"Fattorusso","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.apsb.2026.02.017_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.apsb.2026.02.017_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.semcdb.2019.04.002","article-title":"The astrocyte biochemistry","volume":"95","author":"Souza","year":"2019","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.apsb.2026.02.017_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41593-022-01044-2","article-title":"Altered adult neurogenesis and gliogenesis in patients with mesial temporal lobe epilepsy","volume":"25","author":"Ammothumkandy","year":"2022","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2026.02.017_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.neuroscience.2009.03.048","article-title":"The concentrations and distributions of three C-terminal variants of the GLT1 (EAAT2; slc1a2) glutamate transporter protein in rat brain tissue suggest differential regulation","volume":"162","author":"Holmseth","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.apsb.2026.02.017_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1212\/WNL.52.3.453","article-title":"Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy","volume":"52","author":"Mathern","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2026.02.017_bib10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12035-018-1117-6","article-title":"White matter microstructure in bipolar disorder is influenced by the interaction between a glutamate transporter EAAT1 gene variant and early stress","volume":"56","author":"Poletti","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.apsb.2026.02.017_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fnagi.2018.00122","article-title":"Glutamate transporter GLT1 expression in Alzheimer disease and dementia with Lewy bodies","volume":"10","author":"Garcia-Esparcia","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.apsb.2026.02.017_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1600-0463.2009.02443.x","article-title":"Excitatory amino acid transporters EAAT-1 and EAAT-2 in temporal lobe and hippocampus in intractable temporal lobe epilepsy","volume":"117","author":"Sarac","year":"2009","journal-title":"APMIS"},{"key":"10.1016\/j.apsb.2026.02.017_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-022-02437-0","article-title":"Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease","volume":"144","author":"Iovino","year":"2022","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.apsb.2026.02.017_bib14","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1523\/JNEUROSCI.0861-08.2008","article-title":"Glutamate transporters regulate lesion-induced plasticity in the developing somatosensory cortex","volume":"28","author":"Takasaki","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2026.02.017_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1084\/jem.20160667","article-title":"Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy","volume":"214","author":"Sha","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2026.02.017_bib16","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4155\/fmc.12.122","article-title":"Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases","volume":"4","author":"Lin","year":"2012","journal-title":"Future Med Chem"},{"key":"10.1016\/j.apsb.2026.02.017_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106260","article-title":"Natural HSP90 inhibitors as a potential therapeutic intervention in treating cancers: a comprehensive review","volume":"181","author":"Liew","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.02.017_bib18","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.freeradbiomed.2010.03.001","article-title":"Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs","volume":"48","author":"Samuni","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.02.017_bib19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7164\/antibiotics.23.442","article-title":"Geldanamycin, a new antibiotic","volume":"23","author":"DeBoer","year":"1970","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.apsb.2026.02.017_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1379\/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2","article-title":"Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin","volume":"3","author":"Schulte","year":"1998","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.apsb.2026.02.017_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00689048","article-title":"Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent","volume":"36","author":"Supko","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.apsb.2026.02.017_bib22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/cbdd.13486","article-title":"Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment","volume":"93","author":"Talaei","year":"2019","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.apsb.2026.02.017_bib23","first-page":"8984","article-title":"Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity","volume":"63","author":"Bisht","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2026.02.017_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0006-8993(01)03124-9","article-title":"Na+ dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: effect of oxidative stress","volume":"922","author":"Miralles","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.apsb.2026.02.017_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107095","article-title":"Long-term outcomes of classic and novel anti-seizure medication in a kainate-induced model of chronic epilepsy","volume":"191","author":"Li","year":"2023","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.apsb.2026.02.017_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105637","article-title":"Robust chronic convulsive seizures, high frequency oscillations, and human seizure onset patterns in an intrahippocampal kainic acid model in mice","volume":"166","author":"Lisgaras","year":"2022","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.apsb.2026.02.017_bib27","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1523\/JNEUROSCI.0980-08.2009","article-title":"Development of spontaneous recurrent seizures after kainate-induced status epilepticus","volume":"29","author":"Williams","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2026.02.017_bib28","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41401-019-0280-2","article-title":"TLR4 deficiency has a protective effect in the MPTP\/probenecid mouse model of Parkinson's disease","volume":"40","author":"Shao","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2026.02.017_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12974-021-02239-3","article-title":"Inhibition of P2X4R attenuates white matter injury in mice after intracerebral hemorrhage by regulating microglial phenotypes","volume":"18","author":"Fu","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.apsb.2026.02.017_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/prot.10101","article-title":"Interaction of Hsp90 with 20S proteasome: thermodynamic and kinetic characterization","volume":"48","author":"Eleuteri","year":"2002","journal-title":"Proteins"},{"key":"10.1016\/j.apsb.2026.02.017_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1990.tb05352.x","article-title":"Parenchymal changes related to plasma protein extravasation in experimental seizures","volume":"31","author":"Sokrab","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.apsb.2026.02.017_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0304-3940(94)11166-G","article-title":"Early and transient increase of rat hippocampal blood\u2013brain barrier permeability to amino acids during kainic acid-induced seizures","volume":"184","author":"Pont","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.apsb.2026.02.017_bib33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0306-4522(84)90089-7","article-title":"The role of brain edema in epileptic brain damage induced by systemic kainic acid injection","volume":"13","author":"Lassmann","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.apsb.2026.02.017_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yebeh.2012.09.027","article-title":"Epilepsy as progressive disorders: what is the evidence that can guide our clinical decisions and how can neuroimaging help?","volume":"26","author":"Coan","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.apsb.2026.02.017_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512519","article-title":"Fluid biomarkers of neuro-glial injury in human status epilepticus: a systematic review","volume":"24","author":"Giovannini","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.02.017_bib36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/epi4.12564","article-title":"Astrocyte reactivity in a mouse model of SCN8A epileptic encephalopathy","volume":"7","author":"Thompson","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.apsb.2026.02.017_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41984-021-00141-x","article-title":"Examining the role of astrogliosis and JNK signaling in post-traumatic epilepsy","volume":"37","author":"Small","year":"2022","journal-title":"Egypt J Neurosurg"},{"key":"10.1016\/j.apsb.2026.02.017_bib38","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2174\/1381612826666200113162641","article-title":"Excitotoxicity as a target against neurodegenerative processes","volume":"26","author":"Binvignat","year":"2020","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.apsb.2026.02.017_bib39","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3390\/ph15101297","article-title":"Targeting NMDA receptor complex in management of epilepsy","volume":"15","author":"Sivakumar","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.apsb.2026.02.017_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2017.09.026","article-title":"Seizure susceptibility in the APP\/PS1 mouse model of Alzheimer's disease and relationship with amyloid \u03b2 plaques","volume":"1677","author":"Reyes-Marin","year":"2017","journal-title":"Brain Res"},{"key":"10.1016\/j.apsb.2026.02.017_bib41","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.neuropharm.2011.01.035","article-title":"Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP\/PS1 mouse model of Alzheimer's disease","volume":"60","author":"Filali","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.apsb.2026.02.017_bib42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fnins.2019.00472","article-title":"Meta-analysis of randomized controlled trials on the efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease","volume":"13","author":"Li","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.apsb.2026.02.017_bib43","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneurol.2011.69","article-title":"Lack of evidence for the efficacy of memantine in mild Alzheimer disease","volume":"68","author":"Schneider","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.apsb.2026.02.017_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0092-8674(00)80314-1","article-title":"Identification and structural characterization of the ATP\/ADP-binding site in the Hsp90 molecular chaperone","volume":"90","author":"Prodromou","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.02.017_bib45","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/cbic.201700616","article-title":"Heat shock proteins revisited: using a mutasynthetically generated reblastatin library to compare the inhibition of human and leishmania Hsp90s","volume":"19","author":"Mohammadi-Ostad-Kalayeh","year":"2018","journal-title":"Chembiochem"},{"key":"10.1016\/j.apsb.2026.02.017_bib46","doi-asserted-by":"crossref","first-page":"10006","DOI":"10.1158\/0008-5472.CAN-05-2029","article-title":"Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition","volume":"65","author":"Guo","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2026.02.017_bib47","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1021\/bi0524969","article-title":"Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives","volume":"45","author":"Maroney","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2026.02.017_bib48","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.7164\/antibiotics.53.1310","article-title":"Reblastatin, a novel benzenoid ansamycin-type cell cycle inhibitor","volume":"53","author":"Takatsu","year":"2000","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.apsb.2026.02.017_bib49","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nchem.1596","article-title":"Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90","volume":"5","author":"Kitson","year":"2013","journal-title":"Nat Chem"},{"key":"10.1016\/j.apsb.2026.02.017_bib50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0006-2952(92)90429-M","article-title":"The sensitivity of human tumour cells to quinone bioreductive drugs: what role for DT-diaphorase?","volume":"44","author":"Robertson","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.02.017_bib51","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bmcl.2008.01.072","article-title":"Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity","volume":"18","author":"Onodera","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2026.02.017_bib52","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1021\/jo1000109","article-title":"Synthesis of reblastatin, autolytimycin, and non-benzoquinone analogues: potent inhibitors of heat shock protein 90","volume":"75","author":"Wrona","year":"2010","journal-title":"J Org Chem"},{"key":"10.1016\/j.apsb.2026.02.017_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135391","article-title":"Reactive astrocyte-driven epileptogenesis is induced by microglia initially activated following status epilepticus","volume":"6","author":"Sano","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2026.02.017_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000352","article-title":"An excitatory loop with astrocytes contributes to drive neurons to seizure threshold","volume":"8","author":"G\u00f3mez-Gonzalo","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1016\/j.apsb.2026.02.017_bib55","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1016\/j.apsb.2025.07.034","article-title":"Astrocytic dopamine D1 receptor modulates glutamatergic transmission and synaptic plasticity in the prefrontal cortex through d-serine","volume":"15","author":"Yin","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.02.017_bib56","doi-asserted-by":"crossref","first-page":"8415","DOI":"10.7150\/thno.44721","article-title":"Hsp90 inhibitor HSP990 in very low dose upregulates EAAT2 and exerts potent antiepileptic activity","volume":"10","author":"Sha","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.02.017_bib57","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.apsb.2024.05.031","article-title":"Synthesis and evaluation of TSPO-targeting radioligand [18F]F-TFQC for PET neuroimaging in epileptic rats","volume":"15","author":"Fu","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.02.017_bib58","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.apsb.2022.09.019","article-title":"ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy","volume":"13","author":"Zhou","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.02.017_bib59","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.apsb.2024.01.004","article-title":"Discovery of GluN2A subtype-selective N-methyl-d-aspartate (NMDA) receptor ligands","volume":"14","author":"Jiang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.02.017_bib60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.02.017_bib61","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1126\/science.276.5319.1699","article-title":"Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1","volume":"276","author":"Tanaka","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.02.017_bib62","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/syn.20163","article-title":"Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration","volume":"57","author":"Holmer","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.apsb.2026.02.017_bib63","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cne.21852","article-title":"Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats","volume":"511","author":"Chung","year":"2008","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.apsb.2026.02.017_bib64","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3233\/JAD-180708","article-title":"Ceftriaxone improves cognitive function and upregulates GLT-1-related glutamate-glutamine cycle in APP\/PS1 mice","volume":"66","author":"Fan","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.apsb.2026.02.017_bib65","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.20140413","article-title":"Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease","volume":"212","author":"Takahashi","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2026.02.017_bib66","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.apsb.2024.03.034","article-title":"Monoclonal antibodies and aptamers: the future therapeutics for Alzheimer's disease","volume":"14","author":"Barrera-Ocampo","year":"2024","journal-title":"Acta Pharm Sin B"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221138352600122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221138352600122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:41:53Z","timestamp":1779414113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221138352600122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S221138352600122X"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.02.017","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reblastatin as a neuroprotective agent in temporal lobe epilepsy and excitotoxic conditions of Alzheimer's disease and Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}